CorVel CRVL 深 滬
等待開盤 08-16 09:30:00 美东时间
88.22
-0.190
-0.21%
華盛通- 最 高89.47
- 今 開89.03
- 成交量 13.14万股
- 最 低 87.813
- 昨 收 88.41
- 總市值 45.30亿
- 52周最高 128.61
- 市盈率 靜 48.20
- 換手率 0.00%
- 52周最低 85.13
- 委 比 70.00%
- 總股本 5135.07万
- 歷史最高 128.61
- 量 比 0.88
- 振 幅 1.87%
- 歷史最低 9.36
- 每 手 1
- 風險率 8.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Critical Metals Corp Engages Global Engineering Firm NIRAS to Finalize DFS for Tanbreez in Greenland
Critical Metals Corp (NASDAQ: CRML) announced that Tanbreez Mining Greenland A/S has appointed NIRAS A/S to complete a Definitive Feasibility Study (DFS) for a 500,000 metric tons per annum mining and processing operation at the Tanbreez Rare Earth Project in southern Greenland. The DFS will cover technical, environmental, and commercial aspects, with completion expected in Q4 2025. Critical Metals holds a controlling interest in the project and ...
08-07 12:00
CorVel Reports Strong Quarterly Earnings Growth
Corvel ( ($CRVL) ) has released its Q1 earnings. Here is a breakdown of the inf...
08-06 12:28
CorVel Announces Revenues and Earnings
CorVel Corporation reported Q2 2025 revenue of $235M, up 11% YoY, with EPS of $0.52, a 24% increase. Gross profit rose 18% to $56.8M. The company ended the quarter with $202M in cash and repurchased $9.6M in stock. A technology assets acquisition was completed to bolster CERIS capabilities, expected to drive future growth.
08-05 10:15
Carbon Revolution Secures Final Release of $5 Million from OIC and Final $0.4 Million Reserve Release from Existing Lenders
Carbon Revolution plc received US$5 million from Orion Infrastructure Capital (OIC), completing the US$25 million facility. Additionally, Existing Noteholders released the final US$400,000, raising total reserves to US$2 million. The company issued 5% warrants to OIC and noteholders. The firm faces reduced revenue forecasts due to lower wheel orders and delayed customer payments, slowing expansion plans. They are exploring further financing withi...
07-25 20:30
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
Corvus Pharmaceuticals announced that its leadership team will participate in one-on-one investor meetings and present a corporate overview at the 2025 Jefferies Global Healthcare Conference in New York on June 5, 2025. The presentation will be available via webcast, accessible through the company's investor relations website for 90 days post-event. Corvus specializes in developing ITK inhibition for cancer and immune disease treatments.
05-28 20:01
CorVel Q4 EPS $0.51 Up From $0.37 YoY, Sales $231.51M Up From $207.23M YoY
CorVel (NASDAQ:CRVL) reported quarterly earnings of $0.51 per share. This is a 37.84 percent increase over earnings of $0.37 per share from the same period last year. The company reported $231.51 million in sales this
05-22 18:17
CorVel Corporation Reports Strong Quarterly Earnings
Corvel ( ($CRVL) ) has released its Q3 earnings. Here is a breakdown of the inf...
02-11 11:53
CorVel announces three-for-one forward stock split
CorVel (NASDAQ:CRVL) has announced that its Board of Directors approved a three-for-one forward stock split of its common stock. The Board also approved a proportionate increase in the number of autho...
2024-12-14 05:36
亚马逊云科技在Amazon Bedrock上推出100多个新模型
中关村在线消息，亚马逊云科技在2024 re:Invent全球大会上，宣布推出Amazon Bedrock的多项创新功能。Amazon Bedrock是亚马逊云...
2024-12-06 10:33
CorVel Announces Leadership Transition as Founder Retires
CorVel ( ($CRVL) ) has provided an announcement. CorVel Corporation announced t...
2024-11-30 04:18
